The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation

Abstract

Although increases in plasma ddcfDNA% are associated with graft injury, plasma ddcfDNA does not outperform the diagnostic capacity of the serum creatinine in the diagnosis of acute rejection.